[{"address1": "Robert Koch Strasse 50", "city": "Mainz", "zip": "55129", "country": "Germany", "phone": "49 6131 554 2860", "website": "https://mainzbiomed.com", "industry": "Diagnostics & Research", "industryKey": "diagnostics-research", "industryDisp": "Diagnostics & Research", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Mainz Biomed N.V. develops and sells in-vitro diagnostic tests for the early detection of cancer in the United States. The company offers ColoAlert, a colorectal cancer diagnostic molecular genetic stool test. It also develops PancAlert, a stool-based screening test for the detection of pancreatic cancer. The company was founded in 2008 and is based in Mainz, Germany.", "fullTimeEmployees": 65, "companyOfficers": [{"maxAge": 1, "name": "Mr. Guido  Baechler", "age": 58, "title": "CEO & Executive Director", "yearBorn": 1965, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. William J. Caragol", "age": 56, "title": "Chief Financial Officer", "yearBorn": 1967, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Christopher  Von Torne P.M.P., Ph.D.", "age": 51, "title": "Chief Operating Officer", "yearBorn": 1972, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Frank  Krieg-Schneider", "age": 61, "title": "Chief Technology Officer", "yearBorn": 1962, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Moritz  Eidens Ph.D.", "age": 39, "title": "Chief Science Officer & Executive Director", "yearBorn": 1984, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Stefan  Erlach", "title": "Head of Human Resources", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Philipp  Freese", "age": 40, "title": "Chief Business Officer", "yearBorn": 1983, "exercisedValue": 0, "unexercisedValue": 0}], "maxAge": 86400, "priceHint": 4, "previousClose": 0.4801, "open": 0.469, "dayLow": 0.4, "dayHigh": 0.469, "regularMarketPreviousClose": 0.4801, "regularMarketOpen": 0.469, "regularMarketDayLow": 0.4, "regularMarketDayHigh": 0.469, "beta": 0.141, "forwardPE": -0.64380956, "volume": 1428971, "regularMarketVolume": 1428971, "averageVolume": 542426, "averageVolume10days": 2046820, "averageDailyVolume10Day": 2046820, "bid": 0.3045, "ask": 0.5265, "bidSize": 200, "askSize": 200, "marketCap": 8877205, "fiftyTwoWeekLow": 0.315, "fiftyTwoWeekHigh": 4.9, "priceToSalesTrailing12Months": 9.91336, "fiftyDayAverage": 0.62004, "twoHundredDayAverage": 1.21531, "currency": "USD", "enterpriseValue": 9227050, "floatShares": 18389100, "sharesOutstanding": 21886600, "sharesShort": 282164, "sharesShortPriorMonth": 300862, "sharesShortPreviousMonthDate": 1715731200, "dateShortInterest": 1718323200, "sharesPercentSharesOut": 0.0128999995, "heldPercentInsiders": 0.21632999, "heldPercentInstitutions": 0.00671, "shortRatio": 1.07, "shortPercentOfFloat": 0.0153, "impliedSharesOutstanding": 21886600, "bookValue": 0.154, "priceToBook": 2.6337664, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1703980800, "netIncomeToCommon": -26295728, "trailingEps": -1.62, "forwardEps": -0.63, "enterpriseToRevenue": 10.304, "enterpriseToEbitda": -0.354, "52WeekChange": -0.9109649, "SandP52WeekChange": 0.24919295, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "MYNZ", "underlyingSymbol": "MYNZ", "shortName": "Mainz Biomed N.V.", "longName": "Mainz Biomed N.V.", "firstTradeDateEpochUtc": 1636119000, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "74995154-4535-3bd7-9d98-8548f3c030bf", "messageBoardId": "finmb_1679642292", "gmtOffSetMilliseconds": -14400000, "currentPrice": 0.4056, "targetHighPrice": 4.0, "targetLowPrice": 2.0, "targetMeanPrice": 3.0, "targetMedianPrice": 3.0, "recommendationMean": 2.3, "recommendationKey": "buy", "numberOfAnalystOpinions": 2, "totalCash": 7070925, "totalCashPerShare": 0.323, "ebitda": -26074670, "totalDebt": 7420780, "quickRatio": 0.804, "currentRatio": 0.972, "totalRevenue": 895479, "debtToEquity": 228.386, "revenuePerShare": 0.055, "returnOnAssets": -0.93424004, "returnOnEquity": -3.03203, "freeCashflow": -13606395, "operatingCashflow": -21938844, "revenueGrowth": 0.111, "grossMargins": 0.56915003, "operatingMargins": -30.687128, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-07-11"}]